1.00071

CCDA Selective Supplement

for Campylobacter spp., pkg of 10 vials, For the preparation of Campylobacter Blood Free Selective Agar

• 동의어(들): Blood Free Campylobacter Medium Selective Supplement, Campylobacter Blood-Free Medium Selective Supplement, Campylobacter Selective Supplement
• UNSPSC 코드: 41106212
• NACRES: NA.74

속성

• Agency: ISO 10272; ISO
• Quality Level: 200
• 형태: lyophilized powder
• 구성: Amphotericin B, 5 mg ; Cefoperazone, 16 mg
• 포장: pkg of 10 vials
• 기술: microbiological culture: suitable
• pH: 7.0-7.4 (25 °C, 40 g/L in H₂O, suspension)
• solubility: 40 g/L
• 응용 분야: food and beverages; microbiology
• 저장 온도: 2-8°C
• 적합성: Campylobacter spp.

설명

일반 설명

CCDA Selective Supplement is a mixture of two antibiotics (Amphotericin B & Cefoperazone) in lyophilized form. Amphotericin B largely reduces the growth of yeasts and molds, while Cefoperazone especially inhibits the growth of Enterobacteriaceae.

애플리케이션

CCDA Selective Supplement is an additive used during the preparation of Campylobacter Blood Free Selective Agar for the enrichment of Campylobacter from foods.

결합

Replaces: 1.00071

분석 메모

Typical composition (per vial): Amphotericin B 5.0 mg; Cefoperazone 16.0 mg.

Growth promotion test in accordance with ISO 11133.
Supplement tested with base Art. 1.00070.
Growth
- Campylobacter coli ATCC 43478 (WDCM 00004):
good
- Campylobacter jejuni ATCC 33291 (WDCM 00005): good
- Campylobacter jejuni ATCC 29428 (WDCM 00156): good
- Staphylococcus aureus ATCC 25923 (WDCM 00034): no growth
- Escherichia coli ATCC 25922 (WDCM 00013): inhibited growth
- Escherichia coli ATCC 8739 (WDCM 00012): inhibited growth
Incubation: 44 hrs. 41.5 °C with Anaercult C. E.coli and Staph.aur. aerobic.
Strains tested with three-loop-streak.

안전성 정보

• 픽토그램: GHS08
• 신호어: Danger
• 유해 및 위험 성명서: H317 - H334 - H373
• 예방조치 성명서: P260 - P272 - P280 - P284 - P302 + P352 - P333 + P313
• Hazard Classifications: Resp. Sens. 1 - Skin Sens. 1 - STOT RE 2
• Storage Class Code: 11 - Combustible Solids
• WGK: WGK 3